Importer of Controlled Substances Registration, 5500 [2019-02874]

Download as PDF 5500 Federal Register / Vol. 84, No. 35 / Thursday, February 21, 2019 / Notices Company FR docket Chattem Chemicals .......................................................... 83 FR 56103 ................................................................... The DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of this registrant to manufacture the applicable basic classes of controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated the company’s maintenance of effective controls against diversion by inspecting and testing the company’s physical security systems, verifying the company’s compliance with state and local laws, and reviewing the company’s background and history. Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 CFR 1301.33, the DEA has granted a Dated: January 29, 2019. John J. Martin, Assistant Administrator. [FR Doc. 2019–02867 Filed 2–20–19; 8:45 am] The registrant listed below has applied for and been granted registration by the Drug Enforcement Administration (DEA) as a bulk manufacturer of various classes of schedule II controlled substances. The company listed below applied to be registered as a bulk manufacturer of various basic classes of controlled substances. Information on a previously published notice is listed below. No comments or objections were submitted for the notice. SUPPLEMENTARY INFORMATION: BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–392] Bulk Manufacturer of Controlled Substances Registration ACTION: Notice of registration. FR docket Janssen Pharmaceuticals, Inc .......................................... 83 FR 55205 ................................................................... registration as a bulk manufacturer to the above listed company. Dated: January 7, 2019. John J. Martin, Assistant Administrator. [FR Doc. 2019–02868 Filed 2–20–19; 8:45 am] BILLING CODE 4410–09–P Published November 2, 2018. Registrants listed below have applied for and been granted registration by the Drug Enforcement Administration (DEA) as importers of schedule I or schedule II controlled substances. SUMMARY: The companies listed below applied to be registered as importers of various basic classes of controlled substances. Information on the previously published notices is listed in the table below. No comments or objections were submitted and no requests for hearing were submitted for these notices. SUPPLEMENTARY INFORMATION: DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–392] Importer of Controlled Substances Registration ACTION: November 9, 2018. SUMMARY: Company The DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of this registrant to manufacture the applicable basic classes of controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated the company’s maintenance of effective controls against diversion by inspecting and testing the company’s physical security systems, verifying the company’s compliance with state and local laws, and reviewing the company’s background and history. Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 CFR 1301.33, the DEA has granted a amozie on DSK3GDR082PROD with NOTICES1 registration as a bulk manufacturer to the above listed company. Published Notice of registration. Company FR docket Mylan Pharmaceuticals, Inc ......................................................................................................................... Siegfried USA, LLC ...................................................................................................................................... 83 FR 64158 83 FR 64158 The DEA has considered the factors in 21 U.S.C. 823, 952(a) and 958(a) and determined that the registration of the listed registrants to import the applicable basic classes of schedule I or II controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated each of the company’s maintenance of effective controls VerDate Sep<11>2014 17:08 Feb 20, 2019 Jkt 247001 against diversion by inspecting and testing each company’s physical security systems, verifying each company’s compliance with state and local laws, and reviewing each company’s background and history. Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the DEA has granted registrations as importers for schedule II controlled substances to the above listed companies. PO 00000 Frm 00097 Fmt 4703 Sfmt 9990 Published December 13, 2018. December 13, 2018. Dated: January 29, 2019. John J. Martin, Assistant Administrator. [FR Doc. 2019–02874 Filed 2–20–19; 8:45 am] BILLING CODE 4410–09–P E:\FR\FM\21FEN1.SGM 21FEN1

Agencies

[Federal Register Volume 84, Number 35 (Thursday, February 21, 2019)]
[Notices]
[Page 5500]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-02874]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Importer of Controlled Substances Registration

ACTION: Notice of registration.

-----------------------------------------------------------------------

SUMMARY: Registrants listed below have applied for and been granted 
registration by the Drug Enforcement Administration (DEA) as importers 
of schedule I or schedule II controlled substances.

SUPPLEMENTARY INFORMATION: The companies listed below applied to be 
registered as importers of various basic classes of controlled 
substances. Information on the previously published notices is listed 
in the table below. No comments or objections were submitted and no 
requests for hearing were submitted for these notices.

----------------------------------------------------------------------------------------------------------------
                 Company                             FR docket                          Published
----------------------------------------------------------------------------------------------------------------
Mylan Pharmaceuticals, Inc...............  83 FR 64158                   December 13, 2018.
Siegfried USA, LLC.......................  83 FR 64158                   December 13, 2018.
----------------------------------------------------------------------------------------------------------------

    The DEA has considered the factors in 21 U.S.C. 823, 952(a) and 
958(a) and determined that the registration of the listed registrants 
to import the applicable basic classes of schedule I or II controlled 
substances is consistent with the public interest and with United 
States obligations under international treaties, conventions, or 
protocols in effect on May 1, 1971. The DEA investigated each of the 
company's maintenance of effective controls against diversion by 
inspecting and testing each company's physical security systems, 
verifying each company's compliance with state and local laws, and 
reviewing each company's background and history.
    Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in 
accordance with 21 CFR 1301.34, the DEA has granted registrations as 
importers for schedule II controlled substances to the above listed 
companies.

    Dated: January 29, 2019.
John J. Martin,
Assistant Administrator.
[FR Doc. 2019-02874 Filed 2-20-19; 8:45 am]
 BILLING CODE 4410-09-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.